Company research
Day One Biopharmaceuticals, Inc.
CIK 1845337Updated Sep 27, 2026
Securities
Historical securities (1)
DAWN · NASDAQ · equity · closed Apr 22, 2026Name history
Day One Biopharmaceuticals Holding Co LLC · through May 26, 2021
DAWN price & chart
Historical security
This listing closed Apr 22, 2026. Live provider charts are shown only for current listings.
In the news
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? ↗
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio ↗
Seeking Alpha
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on ↗
Biotech Is Holding Steady In 2026 ↗
Top performing mid-cap stocks YTD as volatility hits markets ↗
SEC disclosures
Day One Biopharmaceuticals, Inc. files 8-K: Material Event ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 507,827,000Source | 582,788,000Source | 376,048,000Source | 349,062,000Source |
| Property, Plant and Equipment, NetUSD | 2,136,000Source | 2,285,000Source | 208,000Source | 20,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 197,078,000Source | 124,968,000Source | 230,784,000Source | 85,262,000Source |
| Inventory, NetUSD | 6,326,000Source | 3,321,000Source | — | — |
| Assets, CurrentUSD | 485,099,000Source | 562,330,000Source | 375,274,000Source | 347,874,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,925,000Source | 13,413,000Source | 8,927,000Source | 5,605,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,342,000Source | 2,422,000Source | 352,000Source | 699,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 66,665,000Source | 80,037,000Source | 29,508,000Source | 17,023,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 10,000Source | 10,000Source | 9,000Source | 7,000Source |
| Additional Paid in CapitalUSD | 1,102,490,000Source | 1,056,738,000Source | 805,107,000Source | 601,771,000Source |
| Retained Earnings (Accumulated Deficit)USD | -661,403,000Source | -554,081,000Source | -458,585,000Source | -269,668,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 65,000Source | 84,000Source | 9,000Source | -71,000Source |
| Stockholders' Equity Attributable to ParentUSD | 441,162,000Source | 502,751,000Source | 346,540,000Source | 332,039,000Source |
| Liabilities and EquityUSD | 507,827,000Source | 582,788,000Source | 376,048,000Source | 349,062,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 60,522,000Source | 73,451,000Source | 29,508,000Source | 16,615,000Source |
| Operating Lease, Liability, CurrentUSD | 174,000Source | 10,000Source | 408,000Source | 405,000Source |
| Accounts Payable, CurrentUSD | 3,733,000Source | 3,262,000Source | 2,576,000Source | 260,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,619,000Source | 2,592,000Source | 0Source | 408,000Source |
| Other Liabilities, NoncurrentUSD | 484,000Source | 761,000Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | — | 15,950,000Source |
| Deferred Revenue, CurrentUSD | 2,000,000Source | 1,554,000Source | — | — |
| Deferred Revenue, NoncurrentUSD | 3,040,000Source | 3,233,000Source | — | — |
| Short-term InvestmentsUSD | 244,035,000Source | 406,752,000Source | 135,563,000Source | 257,007,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -188,917,000Source | -142,181,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 366,000Source | 92,000Source | 36,000Source | 63,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 12,859,000Source | 13,876,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | 471,000Source | 686,000Source | 2,316,000Source | -1,484,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -103,757,000Source | -78,113,000Source | -146,853,000Source | -109,874,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 174,648,000Source | -230,994,000Source | 128,378,000Source | -255,074,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 320,000Source | 2,169,000Source | 224,000Source | 26,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,219,000Source | 203,291,000Source | 163,997,000Source | 165,901,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | 145,522,000Source | -199,047,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 197,078,000Source | 124,968,000Source | 230,784,000Source | 85,262,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 4,749,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 44,388,000Source | 48,263,000Source | 39,341,000Source | 27,242,000Source |
| Amortization of Intangible AssetsUSD | 3,110,000Source | 1,470,000Source | — | — |
| DepreciationUSD | — | — | — | 63,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -71,000Source | — | — | — |
| General and Administrative ExpenseUSD | 120,587,000Source | 115,450,000Source | 75,543,000Source | 61,291,000Source |
| Income Tax Expense (Benefit)USD | -1,976,000Source | 7,144,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -107,322,000,000Source | -95,496,000Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -188,917,000Source | -142,181,000Source |
| Nonoperating Income (Expense)USD | 18,452,000Source | 128,918,000Source | — | — |
| Operating ExpensesUSD | 285,932,000Source | 348,431,000Source | 206,064,000Source | 146,909,000Source |
| Other Nonoperating Income (Expense)USD | -19,000Source | 1,217,000Source | -40,000Source | -18,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 0Source | 161,409,000Source | 161,610,000Source |
| Proceeds from Stock Options ExercisedUSD | 126,000Source | 2,267,000Source | 1,338,000Source | 3,649,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 158,182,000Source | 131,161,000Source | — | — |
| Operating Income (Loss)USD | -127,750,000Source | -217,270,000Source | -206,064,000Source | -146,909,000Source |
| Other Nonoperating Income (Expense)USD | -19,000Source | 1,217,000Source | -40,000Source | -18,000Source |
| Income Tax Expense (Benefit)USD | -1,976,000Source | 7,144,000Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -107,322,000,000Source | -95,496,000Source | — | — |
| Earnings Per Share, BasicUSD per share | -1.04Source | -1.02Source | -2.37Source | -2.17Source |
| Earnings Per Share, DilutedUSD per share | -1.04Source | -1.02Source | -2.37Source | -2.17Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 103,205,703Source | 93,234,195Source | 79,773,004Source | 65,466,773Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 103,205,703Source | 93,234,195Source | 79,773,004Source | 65,466,773Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 3,110,000Source | 1,470,000Source | — | — |
| Current Income Tax Expense (Benefit)USD | 1,976,000Source | — | — | — |
| General and Administrative ExpenseUSD | 120,587,000Source | 115,450,000Source | 75,543,000Source | 61,291,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -109,298,000Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | — | 4,746,000Source |
| Investment Income, NetUSD | 18,471,000Source | 19,701,000Source | 17,187,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -188,917,000Source | -142,181,000Source |
| Nonoperating Income (Expense)USD | 18,452,000Source | 128,918,000Source | — | — |
| Operating ExpensesUSD | 285,932,000Source | 348,431,000Source | 206,064,000Source | 146,909,000Source |
| Other ExpensesUSD | 0Source | 0Source | — | — |
| Research and Development ExpenseUSD | 148,135,000Source | 227,702,000Source | 130,521,000Source | 85,618,000Source |